---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-011808"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:29:28.733499+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GeneDx holders approve reverse split (1:10-1:50), new shares for $150M offering

## Summary
- Reverse stock split authorized at ratio 1:10 to 1:50, exact ratio set by board.
- Stock issuance of 22,336,624 shares approved for previously announced $150M offering.
- Officer exculpation amendment to charter approved (567M for vs 33M against).
- Equity incentive plan share reserve increased by 26M shares (503.9M for vs 97.2M against).
- Special meeting vote totals: 599,953,892 for reverse split; 595,937,112 for stock issuance.

## SEC filing metadata
- accession: 0001628280-23-011808
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000162828023011808/0001628280-23-011808-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000162828023011808/smfr-20230414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-011808
- JSON: https://secwatch.observer/filing/0001628280-23-011808.json
- Plain text: https://secwatch.observer/filing/0001628280-23-011808.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.